Total Debt for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total debt is $47.14B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$47.14B
YoY change
-7.9%
5Y CAGR
-1.8%
Peak year (2020)
$51.67B
Latest annual
$47.14B
Total Debt history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Total Debt history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $47.14B | -7.9% | ||
| 2024 | $51.20B | +23.5% | ||
| 2023 | $41.46B | +1.8% | ||
| 2022 | $40.72B | -10.7% | ||
| 2021 | $45.60B | -11.8% | ||
| 2020 | $51.67B | +8.7% | ||
| 2019 | $47.54B | +546.9% | ||
| 2018 | $7.35B | -7.7% | ||
| 2017 | $7.96B | +18.7% | ||
| 2016 | $6.71B | +0.3% | ||
| 2015 | $6.69B | -14.6% | ||
| 2014 | $7.83B | -6.1% | ||
| 2013 | $8.34B | +12.8% | ||
| 2012 | $7.39B | +34.7% | ||
| 2011 | $5.49B | +0.8% | ||
| 2010 | $5.45B | -14.4% | ||
| 2009 | $6.36B | -5.6% | ||
| 2008 | $6.74B | +7.4% | ||
| 2007 | $6.27B | -15.6% | ||
| 2006 | $7.43B | -13.5% | ||
| 2005 | $8.60B | -16.9% | ||
| 2004 | $10.35B | +18.2% | ||
| 2003 | $8.75B | +14.6% | ||
| 2002 | $7.64B | +19.2% | ||
| 2001 | $6.41B | +328.0% | ||
| 2000 | $1.50B | -15.6% | ||
| 1999 | $1.77B | -3.9% | ||
| 1998 | $1.85B | +1.3% | ||
| 1997 | $1.82B | +23.2% | ||
| 1996 | $1.48B | +22.2% | ||
| 1995 | $1.21B | -11.6% | ||
| 1994 | $1.37B | +79.0% | ||
| 1993 | $765.00M | +38.8% | ||
| 1992 | $551.00M | -19.9% | ||
| 1991 | $688.00M | +9.6% | ||
| 1990 | $628.00M | +21.2% | ||
| 1989 | $518.00M | -46.2% | ||
| 1988 | $963.00M | +38.8% | ||
| 1987 | $694.00M | — |
Total Debt values are taken from Bristol-Myers Squibb's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Bristol-Myers Squibb (BMY) total debt is $47.14B – declined 7.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bristol-Myers Squibb total debt compounded at -1.8% per year, with a net decline across the window.
The dataset's maximum total debt sits at $51.67B (2020); the minimum reading of $518.00M dates to 1989.
Bristol-Myers Squibb (BMY) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.
Bristol-Myers Squibb Total Debt by Year
Bristol-Myers Squibb Total Debt 2025: $47.14B
Bristol-Myers Squibb total debt in 2025 was $47.14B, declined 7.9% below 2024.
Bristol-Myers Squibb Total Debt 2024: $51.20B
Bristol-Myers Squibb total debt in 2024 was $51.20B, grew 23.5% from 2023.
Bristol-Myers Squibb Total Debt 2023: $41.46B
Bristol-Myers Squibb total debt in 2023 was $41.46B, edged up 1.8% from 2022.
Bristol-Myers Squibb Total Debt 2022: $40.72B
Bristol-Myers Squibb total debt in 2022 was $40.72B, declined 10.7% below 2021.
Bristol-Myers Squibb Total Debt 2021: $45.60B
Bristol-Myers Squibb total debt in 2021 was $45.60B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Total Debt
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's total debt?
- Latest reported total debt for Bristol-Myers Squibb (BMY) is $47.14B (period ending December 31, 2025).
How has Bristol-Myers Squibb total debt changed year-over-year?
- Bristol-Myers Squibb (BMY) total debt changed -7.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb total debt?
- Bristol-Myers Squibb (BMY) total debt compound annual growth rate is -1.8% over the most recent 5 years available.
When did Bristol-Myers Squibb total debt hit its highest annual value?
- Bristol-Myers Squibb total debt reached its highest annual value of $51.67B in 2020.
What was Bristol-Myers Squibb total debt in 2024?
- Bristol-Myers Squibb (BMY) total debt in 2024 was $51.20B.
What was Bristol-Myers Squibb total debt in 2025?
- Bristol-Myers Squibb (BMY) total debt in 2025 was $47.14B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.